Accumulating evidence has shown that multiple lipogenic enzymes, such as FASN, ACC, SCD1, and ACLY, are aberrantly upregulated in a wide variety of cancers, driving FA synthesis and contributing to lipogenesis and the progression of cancer cells [47–50]. The gene discussed is ACLY; the disease is cancer.